活性氧物种放大器用于亡 - 亡介导的瘤高效率放射敏感化
Ze Wang1,2, Xiaojun Ren1,3, Yunfeng Li1
1Department of Radiation Oncology, The Second Hospital of Jilin University, Changchun 130041, P. R. China.
ACS nano
|April 1, 2024
概括
这项研究介绍了Au/Cu纳米点 (Au/CuNDs) 作为一种超音波纳米平台,通过放大反应性氧物种 (ROS) 生成,诱导亡和铁亡,并实现精确癌症治疗的双模式成像来增强放射治疗 (RT).
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 放射治疗 (RT) 的疗效受到不足的活性氧物种 (ROS) 生产和放射电阻的限制.
- 开发新的生物材料来增强ROS生成对于提高RT敏感性至关重要.
研究的目的:
- 为了设计和评估一个theranostic纳米平台,Au/Cu纳米点 (Au/CuNDs),用于精确的放射治疗.
- 为了放大ROS生成,诱导亡和铁亡,并使双模式成像用于增强RT.
主要方法:
- Au/Cu纳米点 (Au/CuNDs) 被合成为一个神经学平台.
- 通过光子吸收,类似触酶的活性和谷氨酸耗尽,ROS生成被放大.
- 亡和铁亡是通过ROS和电离辐射诱导的.
- 双模式成像 (NIRF和CT) 用于瘤可视化.
主要成果:
- 通过多种机制,Au/CuNDs显著放大了ROS产量.
- 结合的ROS和RT有效诱导了细胞亡和铁亡,提高了治疗结果.
- 该纳米平台展示了用于瘤检测的高分辨率双模式成像能力.
- 通过成像指导的精确RT将周围正常组织的损伤降至最低.
结论:
- 开发的Au/CuNDs神经学纳米平台集成了双模式成像,并通过ROS激活的亡-铁亡来使RT敏感.
- 这种方法为临床癌症诊断和图像引导精确放射治疗提供了一个有希望的策略.
- Au/CuND具有提高癌症治疗疗效和减少副作用的潜力.
相关概念视频
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Electron Transport Chain: Complex I and II
13.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.2K


